ArriVent BioPharma, Inc. Common Stock
$28.45
▼ 1.65
(-5.48%)
Volume: 653,151
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
41
- 21d momentum -8.6%
- RSI 42
🎯
Pullback
62
- Near lower Bollinger band
- -3.7% vs 20MA
💎
Value
58
- -21% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)42.3
MACD+0.076
MA trendMixed
ATR5.07%
21d mom.-8.6%
63d mom.-16.3%
vs 20MA-3.7%
RVOL(20)1.16×
52w low · 17
52w high · 36
-20.6% from 52-week high
20d support 27
· resistance 31
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$1.5B
PER—
PBR4.05
PSR—
EPS$-3.32
ROE-44.6%
ROA-41.5%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-7.41
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -1.56% | -8.64% | -16.32% | +30.47% | +59.29% | +36.78% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -8.08%, daily vol 2.91%. ArriVent BioPharma, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.